Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Denise Galloway

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Carter Joseph J; Paulson Kelly G; Wipf Greg C; Miranda Danielle; Madeleine Margaret M; Johnson Lisa G; Lemos Bianca D; Lee Sherry; Warcola Ashley H; Iyer Jayasri G; Nghiem Paul; Galloway Denise A
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma.
Jiang Mingjun; Xi Long Fu; Edelstein Zoe R; Galloway Denise A; Olsem Gary J; Lin William Chun-Che; Kiviat Nancy B
Identification of recombinant human papillomavirus type 16 variants.
Katzenellenbogen Rachel A; Vliet-Gregg Portia; Xu Mei; Galloway Denise A
NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Denise Galloway (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Carter Joseph J; Paulson Kelly G; Wipf Greg C; Miranda Danielle; Madeleine Margaret M; Johnson Lisa G; Lemos Bianca D; Lee Sherry; Warcola Ashley H; Iyer Jayasri G; Nghiem Paul; Galloway Denise A
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma.
Journal of the National Cancer Institute 2009;101(21):1510-22.
2009: Jiang Mingjun; Xi Long Fu; Edelstein Zoe R; Galloway Denise A; Olsem Gary J; Lin William Chun-Che; Kiviat Nancy B
Identification of recombinant human papillomavirus type 16 variants.
Virology 2009;394(1):8-11.
2009: Katzenellenbogen Rachel A; Vliet-Gregg Portia; Xu Mei; Galloway Denise A
NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes.
Journal of virology 2009;83(13):6446-56.
2009: Edelstein Zoe R; Madeleine Margaret M; Hughes James P; Johnson Lisa G; Schwartz Stephen M; Galloway Denise A; Carter Joseph J; Koutsky Laura A
Age of diagnosis of squamous cell cervical carcinoma and early sexual experience.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(4):1070-6.
2009: Winer Rachel L; Harris Tiffany G; Xi Long Fu; Jansen Kathrin U; Hughes James P; Feng Qinghua; Welebob Carolee; Ho Jesse; Lee Shu-Kuang; Carter Joseph J; Galloway Denise A; Kiviat Nancy B; Koutsky Laura A
Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.
Journal of medical virology 2009;81(4):713-21.
2009: Xi Long Fu; Koutsky Laura A; Castle Philip E; Wheeler Cosette M; Galloway Denise A; Mao Constance; Ho Jesse; Kiviat Nancy B
Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.
Journal of the National Cancer Institute 2009;101(3):153-61.
2009: Howie Heather L; Katzenellenbogen Rachel A; Galloway Denise A
Papillomavirus E6 proteins.
Virology 2009;384(2):324-34.
2008: Underbrink Michael P; Howie Heather L; Bedard Kristin M; Koop Jennifer I; Galloway Denise A
E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation.
Journal of virology 2008;82(21):10408-17.
2008: Xu Mei; Luo Weifeng; Elzi David J; Grandori Carla; Galloway Denise A
NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.
Molecular and cellular biology 2008;28(15):4819-28.
2008: Hussain Shehnaz K; Madeleine Margaret M; Johnson Lisa G; Du Qin; Malkki Mari; Wilkerson Hui-Wen; Farin Federico M; Carter Joseph J; Galloway Denise A; Daling Janet R; Petersdorf Effie W; Schwartz Stephen M
Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(7):1790-9.
2008: Madeleine Margaret M; Johnson Lisa G; Smith Anajane G; Hansen John A; Nisperos Brenda B; Li Sue; Zhao Lue-Ping; Daling Janet R; Schwartz Stephen M; Galloway Denise A
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.
Cancer research 2008;68(9):3532-9.
2008: Bedard Kristin M; Underbrink Michael P; Howie Heather L; Galloway Denise A
The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.
Journal of virology 2008;82(8):3894-902.
2007: Benanti Jennifer A; Wang Myra L; Myers Hadley E; Robinson Kristin L; Grandori Carla; Galloway Denise A
Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.
Molecular cancer research : MCR 2007;5(11):1181-9.
2007: Dominguez-Sola David; Ying Carol Y; Grandori Carla; Ruggiero Luca; Chen Brenden; Li Muyang; Galloway Denise A; Gu Wei; Gautier Jean; Dalla-Favera Riccardo
Non-transcriptional control of DNA replication by c-Myc.
Nature 2007;448(7152):445-51.
2007: Katzenellenbogen Rachel A; Egelkrout Erin M; Vliet-Gregg Portia; Gewin Lindy C; Gafken Philip R; Galloway Denise A
NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
Journal of virology 2007;81(8):3786-96.
2007: Madeleine Margaret M; Anttila Tarja; Schwartz Stephen M; Saikku Pekka; Leinonen Maija; Carter Joseph J; Wurscher Michelle; Johnson Lisa G; Galloway Denise A; Daling Janet R
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
International journal of cancer. Journal international du cancer 2007;120(3):650-5.
2007: Xi Long Fu; Koutsky Laura A; Hildesheim Allan; Galloway Denise A; Wheeler Cosette M; Winer Rachel L; Ho Jesse; Kiviat Nancy B
Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(1):4-10.
2006: Xi Long Fu; Kiviat Nancy B; Hildesheim Allan; Galloway Denise A; Wheeler Cosette M; Ho Jesse; Koutsky Laura A
Human papillomavirus type 16 and 18 variants: race-related distribution and persistence.
Journal of the National Cancer Institute 2006;98(15):1045-52.
2006: Carter Joseph J; Wipf Greg C; Madeleine Margaret M; Schwartz Stephen M; Koutsky Laura A; Galloway Denise A
Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera.
Journal of virology 2006;80(10):4664-72.
2006: Buchinsky Farrel J; Carter Joseph J; Wipf Gregory C; Hughes James P; Koutsky Laura A; Galloway Denise A
Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university women.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):450-3.
2005: Daling Janet R; Madeleine Margaret M; Johnson Lisa G; Schwartz Stephen M; Shera Katherine A; Wurscher Michelle A; Carter Joseph J; Porter Peggy L; Galloway Denise A; McDougall James K; Krieger John N
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease.
International journal of cancer. Journal international du cancer 2005;116(4):606-16.
2005: Orozco Johnnie J; Carter Joseph J; Koutsky Laura A; Galloway Denise A
Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.
Journal of virology 2005;79(15):9503-14.
2005: Grandori Carla; Gomez-Roman Natividad; Felton-Edkins Zoe A; Ngouenet Celine; Galloway Denise A; Eisenman Robert N; White Robert J
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I.
Nature cell biology 2005;7(3):311-8.
2005: Loubière L S; Lambert N C; Madeleine M M; Porter A J; Mullarkey M E; Pang J M; Galloway D A; Furst D E; Nelson J L
HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women.
Rheumatology (Oxford, England) 2005;44(3):318-22.
2005: Mullarkey M E; Stevens A M; McDonnell W M; Loubière L S; Brackensick J A; Pang J M; Porter A J; Galloway D A; Nelson J L
Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis.
Tissue antigens 2005;65(2):199-205.
2005: Galloway D A; Gewin L C; Myers H; Luo W; Grandori C; Katzenellenbogen R A; McDougall J K
Regulation of telomerase by human papillomaviruses.
Cold Spring Harbor symposia on quantitative biology 2005;70():209-15.
2004: Gewin Lindy; Myers Hadley; Kiyono Tohru; Galloway Denise A
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex.
Genes & development 2004;18(18):2269-82.
2004: Engels Eric A; Viscidi Raphael P; Galloway Denise A; Carter Joseph J; Cerhan James R; Davis Scott; Cozen Wendy; Severson Richard K; de Sanjose Silvia; Colt Joanne S; Hartge Patricia
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
Journal of the National Cancer Institute 2004;96(18):1368-74.
2004: Shah Keerti V; Galloway Denise A; Knowles Wendy A; Viscidi Raphael P
Simian virus 40 (SV40) and human cancer: a review of the serological data.
Reviews in medical virology 2004;14(4):231-9.
2004: Daling Janet R; Madeleine Margaret M; Johnson Lisa Godefroy; Schwartz Stephen M; Shera Katherine A; Wurscher Michelle A; Carter Joseph J; Porter Peggy L; Galloway Denise A; McDougall James K
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer.
Cancer 2004;101(2):270-80.
2004: Benanti Jennifer A; Galloway Denise A
The normal response to RAS: senescence or transformation?
Cell cycle (Georgetown, Tex.) 2004;3(6):715-7.
2004: Benanti Jennifer A; Galloway Denise A
Normal human fibroblasts are resistant to RAS-induced senescence.
Molecular and cellular biology 2004;24(7):2842-52.
2004: Grandori Carla; Robinson Kristin L; Galloway Denise A; Swisshelm Karen
Functional link between Myc and the Werner gene in tumorigenesis.
Cell cycle (Georgetown, Tex.) 2004;3(1):22-5.
2003: Carter Joseph J; Wipf Greg C; Benki Sarah F; Christensen Neil D; Galloway Denise A
Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1.
Journal of virology 2003;77(21):11625-32.
2003: Carter Joseph J; Madeleine Margaret M; Wipf Greg C; Garcea Robert L; Pipkin Pam A; Minor Philip D; Galloway Denise A
Lack of serologic evidence for prevalent simian virus 40 infection in humans.
Journal of the National Cancer Institute 2003;95(20):1522-30.
2003: Rosenblatt Karin A; Carter Joseph J; Iwasaki Lori M; Galloway Denise A; Stanford Janet L
Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(8):763-8.
2003: Onda Takashi; Carter Joseph J; Koutsky Laura A; Hughes James P; Lee Shu-Kuang; Kuypers Jane; Kiviat Nancy; Galloway Denise A
Characterization of IgA response among women with incident HPV 16 infection.
Virology 2003;312(1):213-21.
2003: Helt Anna-Marija; Galloway Denise A
Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins.
Carcinogenesis 2003;24(2):159-69.
2002: Madeleine Margaret M; Brumback Babette; Cushing-Haugen Kara L; Schwartz Stephen M; Daling Janet R; Smith Anajane G; Nelson J Lee; Porter Peggy; Shera Katherine A; McDougall James K; Galloway Denise A
Human leukocyte antigen class II and cervical cancer risk: a population-based study.
The Journal of infectious diseases 2002;186(11):1565-74.
2002: Benanti Jennifer A; Williams Dawnnica K; Robinson Kristin L; Ozer Harvey L; Galloway Denise A
Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1.
Molecular and cellular biology 2002;22(21):7385-97.
2002: Helt Anna-Marija; Funk Jens Oliver; Galloway Denise A
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
Journal of virology 2002;76(20):10559-68.
2002: Xi Long Fu; Carter Joseph J; Galloway Denise A; Kuypers Jane; Hughes James P; Lee Shu Kuang; Adam Diane E; Kiviat Nancy B; Koutsky Laura A
Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(4):343-51.
2002: Daling Janet R; Madeleine Margaret M; Schwartz Stephen M; Shera Katherine A; Carter Joseph J; McKnight Barbara; Porter Peggy L; Galloway Denise A; McDougall James K; Tamimi Hisham
A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Gynecologic oncology 2002;84(2):263-70.
2001: Starr J R; Daling J R; Fitzgibbons E D; Madeleine M M; Ashley R; Galloway D A; Schwartz S M
Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk.
Cancer research 2001;61(23):8459-64.
2001: Gewin L; Galloway D A
E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc.
Journal of virology 2001;75(15):7198-201.
2001: Helt A M; Galloway D A
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Journal of virology 2001;75(15):6737-47.
2001: Schwartz S M; Daling J R; Shera K A; Madeleine M M; McKnight B; Galloway D A; Porter P L; McDougall J K
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1906-15.
2001: Madeleine M M; Daling J R; Schwartz S M; Shera K; McKnight B; Carter J J; Wipf G C; Critchlow C W; McDougall J K; Porter P; Galloway D A
Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(3):171-7.
2001: Carter J J; Madeleine M M; Shera K; Schwartz S M; Cushing-Haugen K L; Wipf G C; Porter P; Daling J R; McDougall J K; Galloway D A
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Cancer research 2001;61(5):1934-40.
2000: McShea A; Samuel T; Eppel J T; Galloway D A; Funk J O
Identification of CIP-1-associated regulator of cyclin B (CARB), a novel p21-binding protein acting in the G2 phase of the cell cycle.
The Journal of biological chemistry 2000;275(30):23181-6.
2000: Carter J J; Koutsky L A; Hughes J P; Lee S K; Kuypers J; Kiviat N; Galloway D A
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
The Journal of infectious diseases 2000;181(6):1911-9.
2000: Hagensee M E; Koutsky L A; Lee S K; Grubert T; Kuypers J; Kiviat N B; Galloway D A
Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions.
The Journal of infectious diseases 2000;181(4):1234-9.
2000: Madeleine M M; Shera K; Schwartz S M; Daling J R; Galloway D A; Wipf G C; Carter J J; McKnight B; McDougall J K
The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(2):225-7.
1999: Passalaris T M; Benanti J A; Gewin L; Kiyono T; Galloway D A
The G(2) checkpoint is maintained by redundant pathways.
Molecular and cellular biology 1999;19(9):5872-81.
1999: Wong D J; Foster S A; Galloway D A; Reid B J
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest.
Molecular and cellular biology 1999;19(8):5642-51.
1998: Kiyono T; Foster S A; Koop J I; McDougall J K; Galloway D A; Klingelhutz A J
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.
Nature 1998;396(6706):84-8.
1998: Schwartz S M; Daling J R; Doody D R; Wipf G C; Carter J J; Madeleine M M; Mao E J; Fitzgibbons E D; Huang S; Beckmann A M; McDougall J K; Galloway D A
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.
Journal of the National Cancer Institute 1998;90(21):1626-36.
1998: Xi L F; Critchlow C W; Wheeler C M; Koutsky L A; Galloway D A; Kuypers J; Hughes J P; Hawes S E; Surawicz C; Goldbaum G; Holmes K K; Kiviat N B
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants.
Cancer research 1998;58(17):3839-44.
1998: Foster S A; Wong D J; Barrett M T; Galloway D A
Inactivation of p16 in human mammary epithelial cells by CpG island methylation.
Molecular and cellular biology 1998;18(4):1793-801.
1998: Watts D H; Koutsky L A; Holmes K K; Goldman D; Kuypers J; Kiviat N B; Galloway D A
Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study.
American journal of obstetrics and gynecology 1998;178(2):365-73.
1998: Martin L G; Demers G W; Galloway D A
Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E.
Journal of virology 1998;72(2):975-85.
1998: Galloway D A
Is vaccination against human papillomavirus a possibility?
Lancet 1998;351 Suppl 3():22-4.
1997: Madeleine M M; Daling J R; Carter J J; Wipf G C; Schwartz S M; McKnight B; Kurman R J; Beckmann A M; Hagensee M E; Galloway D A
Cofactors with human papillomavirus in a population-based study of vulvar cancer.
Journal of the National Cancer Institute 1997;89(20):1516-23.
1997: Hagensee M E; Kiviat N; Critchlow C W; Hawes S E; Kuypers J; Holte S; Galloway D A
Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
The Journal of infectious diseases 1997;176(3):625-31.
1997: Funk J O; Waga S; Harry J B; Espling E; Stillman B; Galloway D A
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
Genes & development 1997;11(16):2090-100.
1997: Xi L F; Koutsky L A; Galloway D A; Kuypers J; Hughes J P; Wheeler C M; Holmes K K; Kiviat N B
Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia.
Journal of the National Cancer Institute 1997;89(11):796-802.
1997: Carter J J; Galloway D A
Humoral immune response to human papillomavirus infection.
Clinics in dermatology 1997;15(2):249-59.
1996: Galloway D A; McDougall J K
The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia.
Seminars in cancer biology 1996;7(6):309-15.
1996: Russell K J; Wiens L W; Demers G W; Galloway D A; Le T; Rice G C; Bianco J A; Singer J W; Groudine M
Preferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.
International journal of radiation oncology, biology, physics 1996;36(5):1099-106.
1996: Carter J J; Koutsky L A; Wipf G C; Christensen N D; Lee S K; Kuypers J; Kiviat N; Galloway D A
The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.
The Journal of infectious diseases 1996;174(5):927-36.
1996: Galloway D A; Daling J R
Is the evidence implicating human papillomavirus type 16 in esophageal cancer hard to swallow?
Journal of the National Cancer Institute 1996;88(20):1421-3.
1996: Demers G W; Espling E; Harry J B; Etscheid B G; Galloway D A
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.
Journal of virology 1996;70(10):6862-9.
1996: Christensen N D; Dillner J; Eklund C; Carter J J; Wipf G C; Reed C A; Cladel N M; Galloway D A
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Virology 1996;223(1):174-84.
1996: Daling J R; Madeleine M M; McKnight B; Carter J J; Wipf G C; Ashley R; Schwartz S M; Beckmann A M; Hagensee M E; Mandelson M T; Galloway D A
The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(7):541-8.
1996: Galloway D A
Papillomavirus oncoproteins as vaccine candidates.
Lancet 1996;347(9014):1498-9.
1996: Foster S A; Galloway D A
Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells.
Oncogene 1996;12(8):1773-9.
1996: Hawkins D S; Demers G W; Galloway D A
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Cancer research 1996;56(4):892-8.
1996: Wahl A F; Donaldson K L; Fairchild C; Lee F Y; Foster S A; Demers G W; Galloway D A
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis.
Nature medicine 1996;2(1):72-9.
1995: Xi L F; Demers G W; Koutsky L A; Kiviat N B; Kuypers J; Watts D H; Holmes K K; Galloway D A
Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection.
The Journal of infectious diseases 1995;172(3):747-55.
1995: Russell K J; Wiens L W; Demers G W; Galloway D A; Plon S E; Groudine M
Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.
Cancer research 1995;55(8):1639-42.
1995: Hagensee M E; Carter J J; Wipf G C; Galloway D A
Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies.
Virology 1995;206(1):174-82.
1994: Etscheid B G; Foster S A; Galloway D A
The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53.
Virology 1994;205(2):583-5.
1994: Foster S A; Demers G W; Etscheid B G; Galloway D A
The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.
Journal of virology 1994;68(9):5698-705.
1994: Galloway D A
Human papillomavirus vaccines: a warty problem.
Infectious agents and disease 1994;3(4):187-93.
1994: Hagensee M E; Olson N H; Baker T S; Galloway D A
Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids.
Journal of virology 1994;68(7):4503-5.
1994: Demers G W; Foster S A; Halbert C L; Galloway D A
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(10):4382-6.
1994: Carter J J; Hagensee M B; Lee S K; McKnight B; Koutsky L A; Galloway D A
Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts.
Virology 1994;199(2):284-91.
1994: Demers G W; Halbert C L; Galloway D A
Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene.
Virology 1994;198(1):169-74.
1994: Galloway D A; Demers G W; Foster S A; Halbert C L; Russell K
Cell cycle checkpoint control is bypassed by human papillomavirus oncogenes.
Cold Spring Harbor symposia on quantitative biology 1994;59():297-306.
1993: Yaegashi N; Xi L; Batra M; Galloway D A
Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16.
The Journal of infectious diseases 1993;168(3):743-7.
1993: Xi L F; Demers W; Kiviat N B; Kuypers J; Beckmann A M; Galloway D A
Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis.
The Journal of infectious diseases 1993;168(3):610-7.
1993: Carter J J; Hagensee M; Taflin M C; Lee S K; Koutsky L A; Galloway D A
HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts.
Virology 1993;195(2):456-62.
1993: Chen L; Ashe S; Singhal M C; Galloway D A; Hellström I; Hellström K E
Metastatic conversion of cells by expression of human papillomavirus type 16 E6 and E7 genes.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(14):6523-7.
1993: Hagensee M E; Yaegashi N; Galloway D A
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
Journal of virology 1993;67(1):315-22.
1992: Koutsky L A; Holmes K K; Critchlow C W; Stevens C E; Paavonen J; Beckmann A M; DeRouen T A; Galloway D A; Vernon D; Kiviat N B
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
The New England journal of medicine 1992;327(18):1272-8.
1992: Mandelson M T; Jenison S A; Sherman K J; Valentine J M; McKnight B; Daling J R; Galloway D A
The association of human papillomavirus antibodies with cervical cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(4):281-6.
1992: Chen L; Mizuno M T; Singhal M C; Hu S L; Galloway D A; Hellström I; Hellström K E
Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(8):2617-21.
1992: Halbert C L; Demers G W; Galloway D A
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells.
Journal of virology 1992;66(4):2125-34.
1992: Yaegashi N; Jenison S A; Batra M; Galloway D A
Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11.
Journal of virology 1992;66(4):2008-19.
1991: Carter J J; Yaegashi N; Jenison S A; Galloway D A
Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae.
Virology 1991;182(2):513-21.
1991: Yaegashi N; Jenison S A; Valentine J M; Dunn M; Taichman L B; Baker D A; Galloway D A
Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.
Journal of virology 1991;65(3):1578-83.
1991: Jenison S A; Yu X P; Valentine J M; Galloway D A
Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18.
Journal of virology 1991;65(3):1208-18.
1991: Beckmann A M; Sherman K J; Myerson D; Daling J R; McDougall J K; Galloway D A
Comparative virologic studies of condylomata acuminata reveal a lack of dual infections with human papillomaviruses.
The Journal of infectious diseases 1991;163(2):393-6.
1991: Halbert C L; Demers G W; Galloway D A
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells.
Journal of virology 1991;65(1):473-8.
1990: Kiviat N B; Koutsky L A; Critchlow C W; Galloway D A; Vernon D A; Peterson M L; McElhose P E; Pendras S J; Stevens C E; Holmes K K
Comparison of Southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33, and 35.
American journal of clinical pathology 1990;94(5):561-5.
1990: Jenison S A; Yu X P; Valentine J M; Koutsky L A; Christiansen A E; Beckmann A M; Galloway D A
Evidence of prevalent genital-type human papillomavirus infections in adults and children.
The Journal of infectious diseases 1990;162(1):60-9.
1990: Galloway D A; McDougall J K
Alterations in the cellular phenotype induced by herpes simplex viruses.
Journal of medical virology 1990;31(1):36-42.
1990: Christensen N D; Kreider J W; Cladel N M; Galloway D A
Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins.
Virology 1990;175(1):1-9.
1990: Galloway D A; Jenison S A
Characterization of the humoral immune response to genital papillomaviruses.
Molecular biology & medicine 1990;7(1):59-72.
1989: Firzlaff J M; Galloway D A; Eisenman R N; Lüscher B
The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
The New biologist 1989;1(1):44-53.
1989: Kiviat N B; Koutsky L A; Paavonen J A; Galloway D A; Critchlow C W; Beckmann A M; McDougall J K; Peterson M L; Stevens C E; Lipinski C M
Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic.
The Journal of infectious diseases 1989;159(2):293-302.
1989: Jenison S A; Yu X P; Valentine J M; Galloway D A
Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.
Journal of virology 1989;63(2):809-18.
1989: Galloway D A; McDougall J K
Human papillomaviruses and carcinomas.
Advances in virus research 1989;37():125-71.
1988: Lockshon D; Galloway D A
Sequence and structural requirements of a herpes simplex viral DNA replication origin.
Molecular and cellular biology 1988;8(10):4018-27.
1988: Firzlaff J M; Kiviat N B; Beckmann A M; Jenison S A; Galloway D A
Detection of human papillomavirus capsid antigens in various squamous epithelial lesions using antibodies directed against the L1 and L2 open reading frames.
Virology 1988;164(2):467-77.
1988: Jenison S A; Firzlaff J M; Langenberg A; Galloway D A
Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.
Journal of virology 1988;62(6):2115-23.
1988: Halbert C L; Galloway D A
Identification of the E5 open reading frame of human papillomavirus type 16.
Journal of virology 1988;62(3):1071-5.
1988: Koutsky L A; Galloway D A; Holmes K K
Epidemiology of genital human papillomavirus infection.
Epidemiologic reviews 1988;10():122-63.
1986: Lockshon D; Galloway D A
Cloning and characterization of oriL2, a large palindromic DNA replication origin of herpes simplex virus type 2.
Journal of virology 1986;58(2):513-21.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Denise Galloway

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Denise Galloway (preview)

All Publications